Discontinuation report ALIMTA
| Report ID | 136207 |
| Drug Identification Number | 02253437 |
| Brand name | ALIMTA |
| Common or Proper name | PEMETREXED DISODIUM FOR INJECTION |
| Company Name | ELI LILLY CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PEMETREXED |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500mg /50mL vial |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-09-17 |
| Actual discontinuation date | 2021-09-17 |
| Remaining supply date | 2021-09-17 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | ALIMTA® 500mg /50mL (DIN 02253437) has been discontinued. The ALIMTA 100mg /10mL vial (DIN 02306433) remains available. |
| Company comments | Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
| Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-09-18 | English | Compare |
| v8 | 2021-09-17 | French | Compare |
| v7 | 2021-09-17 | English | Compare |
| v6 | 2021-09-17 | English | Compare |
| v5 | 2021-09-01 | French | Compare |
| v4 | 2021-09-01 | English | Compare |
| v3 | 2021-03-24 | French | Compare |
| v2 | 2021-03-24 | English | Compare |
| v1 | 2021-03-24 | English | Compare |
Showing 1 to 9 of 9